The DOI matches its Crossref record.
Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease
Abstract
BACKGROUND: Creutzfeldt-Jakob disease (CJD) is a rapidly progressive and fatal neurodegenerative disorder for which there is no noninvasive and disease-specific test for premortem diagnosis. Previous studies have suggested that, in the proper clinical context, the 14-3-3 protein in cerebrospinal fluid is a reliable marker for sporadic CJD. OBJECTIVE: To assess the sensitivity of the cerebrospinal fluid 14-3-3 protein test among patients with definite sporadic CJD. DESIGN AND SETTING: We reviewed cases of sporadic CJD referred to our institution that were ultimately proved by pathological examination and on which cerebrospinal fluid 14-3-3 testing had been performed. PARTICIPANTS: Patients with CJD referred to our institution for clinical and/or pathological evaluation (biopsy- or autopsy-confirmed diagnosis) from January 1, 1998, through July 15, 2002, and on whom 14-3-3 testing had been performed. Thirty-two such patients with definite sporadic CJD were identified. Main Outcome Measure The 14-3-3 test results, from various laboratories, in these 32 patients. RESULTS: Seventeen of the 32 patients had a positive result for the 14-3-3 test, yielding a sensitivity of only 53%. A positive 14-3-3 result was significantly correlated with a shorter time between disease onset and the lumbar puncture for the 14-3-3 test. CONCLUSIONS: Testing for the 14-3-3 protein is only modestly sensitive to sporadic CJD, and we caution against ruling out a diagnosis of the disease on the basis of a negative 14-3-3 result.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
McGuire, L. I., Peden, A. H., Orrú, C. D., Wilham, J. M., Appleford, N. E., Mallinson, G., Andrews, M., Head, M. W., Caughey, B., Will, R. G., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23589 · Cited by 387
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease
Hermann, P., Appleby, B., Brandel, J.-P., Caughey, B., Collins, S., Geschwind, M. D., Green, A., Haïk, S., Kovacs, G. G., Ladogana, A., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30477-4 · Cited by 361
Self-citationCSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
Sanchez-Juan, P., Green, A., Ladogana, A., Cuadrado-Corrales, N., Sáanchez-Valle, R., Mitrováa, E., Stoeck, K., Sklaviadis, T., Kulczycki, J., Hess, K., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000230159.67128.00 · Cited by 293
Skillbäck, T., Rosén, C., Asztely, F., Mattsson, N., Blennow, K., & Zetterberg, H. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6455 · Cited by 207
Geschwind, M. D., Haman, A., & Miller, B. L. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.04.001 · Cited by 143
Self-citation
Metadata
- Authors
- Geschwind, M. D., Martindale, J., Miller, D., DeArmond, S. J., Uyehara-Lock, J., Gaskin, D., Kramer, J. H., Barbaro, N. M., & Miller, B. L.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2003-06-01
- Volume
- 60
- Issue
- 6
- Pages
- 813
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W1976082993
- Cited by
- 169
- References
- 0
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease. https://app.cochat.ai/papers/10.1001/archneur.60.6.813
- The paper
- Geschwind, M. D., Martindale, J., Miller, D., DeArmond, S. J., Uyehara-Lock, J., Gaskin, D., Kramer, J. H., Barbaro, N. M., & Miller, B. L. (2003). Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease. Archives of Neurology. https://doi.org/10.1001/archneur.60.6.813
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.